forum

LYKALABS Share Price Discussion

Lyka Labs Ltd.
Sector: Pharmaceuticals and health care
... Read more
LYKALABS Share Price *
19.85 +0.9 (4.75%)
* (quote may be delayed)

LYKALABS Discussion Forum

Lyka Labs Consolidated June 2019 Net Sales at Rs 14.36 crore, up 0% Y-o-Y
www.moneycontrol.com
Like
reply
Reply
share
Share
Lyka Labs Standalone June 2019 Net Sales at Rs 6.74 crore, down 40.61% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • LYKALABS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization68.94
    Enterprise Value160.06
    Price to Earnings210.23
    Price to Book Value0.7
    Return on Capital Employed-0.02
    Return on Equity-0.11
    Face Value10
    Dividend YieldNA
  • LYKALABS Share Price - Technicals

    keyboard_arrow_down
    LYKALABS - 52 Week High₹46.4
    LYKALABS - 52 Week Low₹14.55
  • LYKALABS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1819.7519.851919.85
    Sep 1718.9518.9518.7518.95
    Sep 1616.8518.0516.8518.05
    Sep 1317.1517.2516.8517.2
    Sep 1217.1517.61717.3
  • LYKALABS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹16.72
    30 Day Moving Average₹17.07
    50 Day Moving Average₹18.28
    100 Day Moving Average₹21.65
    200 Day Moving Average₹26.61
  • LYKALABS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue41.6878.59-0.47
    Operating Profit-0.5118.28-1.03
    Profit Before Tax-11.220.57-20.68
    Net Income-10.840.57-20.02
  • LYKALABS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds98.696.030.03
    Total Liabilities150.1149.550
    Total Assets248.7245.580.01
  • LYKALABS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity6.911.21-0.38
    Cash from Investing Activity-3.35-5.19-0.35
    Cash from Financing Activity-4.48-6.3-0.29
    Net Cash Flow-0.93-0.282.32
  • LYKALABS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.04NA
    Return on Equity-0.110.01
    Return on Capital Employed-0.020.09
  • LYKALABS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.08
    3 Year CAGR Growth in Operating Profit1.98
    3 Year CAGR Growth in EBIDTA-0.09
    3 Year CAGR Growth in Net Income1.08
    3 Yr CAGR Growth - Diluted EPS1.08
  • LYKALABS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.44
    5 Year CAGR Growth in Operating Profit1.25
    5 Year CAGR Growth in EBIDTA-0.1
    5 Year CAGR Growth in Net Income1.1
    3 Yr CAGR Growth - Diluted EPS1.1
  • LYKALABS Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 12 8:33 PM
    Lyka Labs Consolidated June 2019 Net Sales at Rs 14.36 crore, up 0% Y-o-Y
    www.moneycontrol.com
    NewsBot
    Aug 12 8:33 PM
    Lyka Labs Standalone June 2019 Net Sales at Rs 6.74 crore, down 40.61% Y-o-Y
    moneycontrol.com
    NewsBot
    May 20 8:18 PM
    NewsBot
    Apr 1 12:38 AM
    NewsBot
    Feb 13 5:27 PM
    NewsBot
    Jan 11 2:02 PM
    NewsBot
    Nov 2 6:27 PM
  • LYKALABS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.